Featured Courses

Cardiovascular Care for Women: The 10-Q Report and Beyond
2.00
  • AMA PRA Category 1 Credit(s)™
  • Non-physician
Cardiovascular Care for Women: The 10-Q Report and BeyondAn American Journal of Cardiology and American Journal of Medicine Multi-Media WebcastAccording to the The National Coalition for Women’s Health Research’s 10Q Report: Advancing women’s heart health through improved research, diagnosis, and treatment published in June 2011...
An Update on Parkinson’s Disease: Improving Patient Outcomes
1.00
  • Non-physician
  • AMA PRA Category 1 Credit(s)™
An Update on Parkinson’s Disease: Improving Patient OutcomesNeurologists are faced with many challenges in caring for patients with Parkinson’s disease (PD). This chronic, long-term illness that affects at least one million people in the United States requires a coordinated healthcare partnership between the physician and the patient...
Applying Antithrombotic Therapies to Improve Outcomes in Patients with Atrial FibrillationApproximately 15-25%, or 75,000 ischemic strokes are attributed to atrial fibrillation annually within the United States. Atrial fibrillation is the most frequently diagnosed cardiac arrhythmia and affects more than 2.66 million Americans. Moreover, atrial...
Novel Therapeutics in Multiple Sclerosis Management: Clinical Applications
1.00
  • Non-physician
  • AMA PRA Category 1 Credit(s)™
Novel Therapeutics in Multiple Sclerosis Management: Clinical Applications Multiple sclerosis (MS) affects an estimated 300,000 individuals in the United States. No cure exists and while there is a lack of consensus on management, strategies to modify disease course are available. These strategies involve initiating disease modifying...
You Make the Choice, Clinical Decision Making in Diabetes: Use of GLP-1 Receptor Agonists in Clinical PracticeThis informative and evidence-based program will challenge osteopathic family physicians and other healthcare professionals on their knowledge and practice related to the care of patients with diabetes. The use of new glucose-lowering...
ECTRIMS 2012 Highlights--Late Clinical Trial Data in Multiple Sclerosis: The Application of Therapies in ManagementKnowledge gaps in practice exist with respect to multiple sclerosis (MS) management including emerging therapies and their mechanisms of action, potential adverse events of agents, choosing therapies appropriate for severity of...
A Practical Approach to Current and Emerging Therapies for the Community Neurologist--A Challenging Case PresentationAt present, the field of multiple sclerosis (MS) research has made remarkable progress revealing innovative agents, both currently approved for treatment and emerging therapies, which target specific pathways contributing to...
Late Clinical Trial Data in Multiple Sclerosis:The Application of Therapies in ManagementECTRIMS 2012 HighlightsMultiple Sclerosis (MS) research is continuous in its evolution of therapeutic development, focusing on neuroprotective effects and agents with distinctive mechanisms of action allowing for unique safety and efficacy profiles....
The purpose of this educational activity is to examine the status and application of evidence-based individualized patient therapy utilizing companion diagnostics. Oncology-specific challenges will be discussed relative to practical use of companion diagnostics to guide targeted pharmacologic therapy.   Click HERE to begin the program!...
This interactive CME activity is designed to improve individual and team-based care, knowledge and skills. By participating, you will hear faculty review thought-provoking concepts that impact the optimal assessment and treatment of Type 2 Diabetes Mellitus (T2DM) so you can better develop individualized treatment plans for your patients. Given...